Evidence map›Paper›PMID 35152418›Full record

ArticleActa psychiatrica Scandinavica2022

Educational attainment and mortality in schizophrenia.

Martin Tesli, Eirik Degerud, Oleguer Plana-Ripoll, Kristin Gustavson, Fartein Ask Torvik, Eivind Ystrom, Helga Ask, Natalia Tesli, Anne Høye, Camilla Stoltenberg and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Acta psychiatrica Scandinavica, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 2 pooled it
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 2 syntheses or guidelines pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Observational
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Educational attainment and mortality in schizophrenia.Acta psychiatrica Scandinavica · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Martin TesliNorwegian Institute of Public Health, Oslo, Norway.
Eirik DegerudNational Institute of Occupational Health, Oslo, Norway.
Oleguer Plana-RipollDepartment of Economics and Business Economics, National Centre for Register-Based Research, Aarhus University, Aarhus V, Denmark.ORCID 0000-0002-6470-7465
Kristin GustavsonNorwegian Institute of Public Health, Oslo, Norway.ORCID 0000-0002-3047-3234
Fartein Ask TorvikNorwegian Institute of Public Health, Oslo, Norway.ORCID 0000-0003-3984-5978
Eivind YstromNorwegian Institute of Public Health, Oslo, Norway.
Helga AskNorwegian Institute of Public Health, Oslo, Norway.ORCID 0000-0003-0149-5319
Natalia TesliNorwegian Centre for Mental Disorders Research, Oslo University Hospital, Oslo, Norway.
Anne HøyeDivision of Mental Health and Substance Abuse, University Hospital of North Norway, Tromsø, Norway.
Camilla StoltenbergNorwegian Institute of Public Health, Oslo, Norway.
Ted Reichborn-KjennerudNorwegian Institute of Public Health, Oslo, Norway.
Ragnar NesvågNorwegian Institute of Public Health, Oslo, Norway.
Øyvind NaessNorwegian Institute of Public Health, Oslo, Norway.
Norwegian Institute of Public Health · NOOslo University Hospital · NOAarhus University · DKNational Institute of Occupational Health · NOUniversity Hospital of North Norway · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIndividuals suffering from schizophrenia have a reduced life expectancy with cardiovascular disease (CVD) as a major contributor. Low educational attainment is associated with schizophrenia, as well as with all-cause and CVD mortality. However, it is unknown to what extent low educational attainment can explain the increased mortality in individuals with schizophrenia.

aimHere, we quantify associations between educational attainment and all-cause and CVD mortality in individuals with schizophrenia, and compare them with the corresponding associations in the general population.

methodAll Norwegian citizens born between January 1, 1925, and December 31, 1959, were followed up from January 1, 1990, to December 31, 2014. The total sample included 1,852,113 individuals, of which 6548 were registered with schizophrenia. We estimated hazard ratios (HR) for all-cause and CVD mortality with Cox models, in addition to life years lost. Educational attainment for index persons and their parents were included in the models.

resultsIn the general population individuals with low educational attainment had higher risk of all-cause (HR: 1.48 [95% CI: 1.47-1.49]) and CVD (HR: 1.59 [95% CI: 1.57-1.61]) mortality. In individuals with schizophrenia these estimates were substantially lower (all-cause: HR: 1.13 [95% CI: 1.05-1.21] and CVD: HR: 1.12 [95% CI: 0.98-1.27]). Low educational attainment accounted for 3.28 (3.21-3.35) life years lost in males and 2.48 (2.42-2.55) years in females in the general population, but was not significantly associated with life years lost in individuals with schizophrenia. Results were similar for parental educational attainment.

conclusionsOur results indicate that while individuals with schizophrenia in general have lower educational attainment and higher mortality rates compared with the general population, the association between educational attainment and mortality is smaller in schizophrenia subjects than in the general population.

Indexed as

Cardiovascular DiseasesSchizophreniaEducational StatusFemaleHumansMaleProportional Hazards ModelsRisk Factorscardiovascular diseaseeducationmortalityschizophreniasocioeconomic

Identifiers

PMID35152418
PMCPMC9305099
OpenAlexW4212995440

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.